Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Retained Earnings (2020 - 2023)

Cullinan Therapeutics has reported Retained Earnings over the past 4 years, most recently at -$1.1 million for Q3 2023.

  • Quarterly results put Retained Earnings at -$1.1 million for Q3 2023, up 73.25% from a year ago — trailing twelve months through Sep 2023 was -$1.1 million (up 73.25% YoY), and the annual figure for FY2022 was -$47.7 million, up 69.99%.
  • Retained Earnings for Q3 2023 was -$1.1 million at Cullinan Therapeutics, up from -$1.6 million in the prior quarter.
  • Over the last five years, Retained Earnings for CGEM hit a ceiling of $3.9 million in Q2 2022 and a floor of -$171.0 million in Q1 2022.
  • Median Retained Earnings over the past 4 years was -$2.8 million (2022), compared with a mean of -$45.7 million.
  • Biggest five-year swings in Retained Earnings: tumbled 7945350.0% in 2021 and later skyrocketed 103.57% in 2022.
  • Cullinan Therapeutics' Retained Earnings stood at -$2000.0 in 2020, then tumbled by 7945350.0% to -$158.9 million in 2021, then surged by 69.99% to -$47.7 million in 2022, then surged by 97.8% to -$1.1 million in 2023.
  • The last three reported values for Retained Earnings were -$1.1 million (Q3 2023), -$1.6 million (Q2 2023), and -$1.2 million (Q1 2023) per Business Quant data.